Skip to main content
. Author manuscript; available in PMC: 2011 Feb 28.
Published in final edited form as: Cancer Chemother Pharmacol. 2009 Mar 26;64(6):1149–1155. doi: 10.1007/s00280-009-0977-x

Table 2.

Patient characteristics

Total number 14a
Median age (years) 61 (35–70)
Gender 5 Males, 9 females
Race/ethnicity 12 Caucasian, 2 Asian
Karnofsky performance status
 90% 5
 80% 6
 70% 1
 60% 2
Prior treatment 2.5 (1–6)
Primary sites
 Lung cancer (non-small cell)
 Colorectal 2
 Esophagus 1
 Breast 1
 Gastric 1
 Salivary gland 1
 Cervix 1
 Unknown 1
Metastatic sites 3 (1–8)
a

Two patients were not evaluable for toxicity